It has been suggested that long term treatment with L-thyroxine could reduc
ed bone mineral density (BMD), The purpose of this study was to determine w
hether BMD is decreased by L-thyroxine treatment in children. Dual energy X
-ray absorptiometry (DEXA) was used to assess lumbar spine (L2-4) and femur
neck BMD in 40 children aged 9-15 years, taking L-thyroxine (100 mu g/m(2)
/day) for a mean period of 1.45 +/- 0.60 years for colloid diffuse goiter.
Patients were matched with controls for age, sex, weight, height and pubert
al stage. BMD at both the femur neck and lumbar spine was not significantly
different from that of the control group. No correlation was found between
BMD values and TSH levels which is the index of tissue hyperthyroidism. BM
D was also not correlated with duration of the therapy. Osteocalcin, alkali
ne phosphatase, calcitonin and parathormone levels were measured to assess
bone turnover; none of them were significantly different from those of cont
rols and they did not change during follow up. In conclusion we suggest tha
t long-term L-thyroxine therapy in children has no adverse effect on BMD.